Gastroretentive oral high dose zinc preparations
AssigneeAdeona Pharmaceuticals, Inc.
InventorsGeorge J. BREWER, Steve H. KANZER, David A. NEWSOME
Life of this patent
Estimating the term…
Abstract
A sustained-release zinc composition preferably includes potassium bicarbonate. A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a sustained-release zinc composition which preferably includes potassium bicarbonate.
Claims41
An oral dosage form of zinc for human consumption containing potassium bicarbonate and over 100 mg of elemental zinc.
An oral dosage form of zinc for human consumption containing potassium bicarbonate as an antacid.
An oral dosage form of zinc for human oral consumption that contains an effervescent agent, other than a lozenge or mouthwash.
An oral dosage form of zinc that provides over 50 mg of elemental zinc in the first hour and at least 50 mg over at least 6 hours.
An oral dosage form of zinc containing at least 50 mg of elemental zinc and a non-cellulose swelling agent.
An oral dosage form of zinc that approximates the bioavailability curve described in FIG. 2.
An oral dosage form of zinc containing potassium bicarbonate and at least 50 mg of elemental zinc and cysteine.
A gastrorententive formulation containing potassium bicarbonate and zinc acetate.
A gastrorententive formulation containing zinc carnosine.
A composition including the ingredients listed in Rows 1-4 of Column 1 or Column 2 of Table 1 in the specification.
11-13. (canceled)
(canceled)
(canceled)
A pharmaceutical composition suitable for administration to a human containing two or more forms of zinc.
A pharmaceutical composition suitable for administration to a human containing two or more zinc salts.
(canceled)
A pharmaceutical composition suitable for administration to a human containing a calcium channel blocker plus zinc.
A pharmaceutical composition suitable for administration to a human containing potassium bicarbonate as an antacid and zinc.
A pharmaceutical composition suitable for administration to a human containing potassium and zinc.
41-42. (canceled)
A pharmaceutical composition suitable for administration to a human containing distilled water, zinc, and potassium.
(canceled)
Dependencies are inferred from the claim text.